icon

Mounjaro eligibility

Mounjaro (tirzepatide) is a new injectable medicine that can help with weight management by regulating appetite and blood sugar levels.

It has recently been approved for NHS use in England for people with obesity and serious weight-related health problems, but access is currently limited to those with the highest clinical need as part of a phased national rollout.

 

Who Can Get Mounjaro on the NHS?

At first, only people who meet all of the following criteria will be eligible:

1. Body Mass Index (BMI)

A BMI of 40 or more, adjusted for ethnicity.

This means that people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds may qualify at a slightly lower BMI (around 37.5 or more).

2. Weight-Related Health Problems
You must have been diagnosed with at least four of the following conditions:

- Hypertension (high blood pressure requiring medication)

- Type 2 diabetes

- Cardiovascular disease (such as heart disease or stroke)

- Obstructive sleep apnoea (confirmed by a sleep clinic)

- Dyslipidaemia (abnormal blood fats or high cholesterol)

3. Lifestyle Support
You will also need to take part in a support programme to help with healthy eating and physical activity alongside the medication.

 

Access and Referrals

Mounjaro will be prescribed only through specialist NHS weight-management (Tier 3) services.

It is not currently available from GP surgeries for general weight loss.

If you are concerned about your weight or related health conditions, your GP or nurse can assess your BMI and medical history and, if appropriate, refer you to a local Tier 3 service for further support.

 

Further Information

Access to Mounjaro on the NHS is being introduced gradually, with eligibility expanding over time as services develop. We will update this page as national and local NHS guidance evolves.

You can read more on the official NHS England page:
Weight Management Injections – NHS England